Mirati Therapeutics Inc.
MRTX | NASDAQ
$58.70
-$0.10 (-0.17%)
At close: Jan 22, 2024, 04:00 PM ET
-0.17%
(1Y)Key Statistics
Market Data
Market Cap $4.12B
1D Range
58.54 58.99
52W Range
27.30 64.41
Valuation (TTM)
PE -4.87
PB 4.35
EV/EBITDA -4.20
Valuation (NTM)
Forward PE N/A
Forward PEG -0.39
Price Target $102.10
Cash Flow
FCF Yield -14.5%
SBC Adj. FCF Yield -19.1%
SBC Impact -32.3%
Margins
Gross Margin 95.2%
Operating Margin -2002.8%
FCF Margin -1560.4%
Growth (CAGR)
Revenue 3Y | 5Y 46.2% |
32.2%
Dil EPS 3Y | 5Y -10.8% |
-21.7%
FCF 3Y | 5Y -25.7% |
-34.0%
Returns
ROA -61.6%
ROE -61.9%
ROIC -72.3%
Financial Health
Net Cash
$968.41M
Current Ratio 6.96
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
A detailed description of the company is not yet available.
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove MRTX